Improving Patient Outcomes and Quality of Life in Parkinson’s Disease: Evidence-Based Strategies for Early Diagnosis and Treatment
Improving Patient Outcomes and Quality of Life in Parkinson’s Disease: Evidence-Based Strategies for Early Diagnosis and Treatment
Edward Jackson, MD
Clinical Director
North American Center for Continuing Medical Education, LLC
Millstone Township, New Jersey
Thomas L. Davis, MD
Professor of Neurology
Division of Movement Disorders
Vanderbilt School of Medicine
Nashville, Tennessee
Joseph H. Friedman, MD
Director, Movement Disorders Program
Butler Hospital
Professor and the Chief of the Division of Movement Disorders, Department of Neurology
Warren Alpert Medical School of Brown University
Providence, Rhode Island
After completing this activity, participants should be able to:
- Identify preclinical nonmotor features of Parkinson's disease (PD) and the importance of early diagnosis and treatment
- Outline the risks, benefits, and long-term effects of PD medications and adjunct therapies
- Describe the changing role of current PD therapies and future adjunct therapy strategies for PD management
- Apply results from current clinical trials, published data and expert perspectives to the diagnosis and treatment of PD
- Implement current treatment guidelines and evidence-based algorithms for PD treatment
This activity is designed for neurologists and allied staff.
This on-demand webcast is available with synchronized video and slides
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
There is no fee associated with this activity.
Release date: December 27, 2012
Expiration date: December 27, 2013
Estimated time to complete: 1 hour
For questions regarding this educational activity, please call 609-371-1137.
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.
Independent Clinical Reviewer: Daniel Harrison, MD, Assistant Professor of Neurology, Johns Hopkins University School of Medicine, Baltimore Maryland
Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California
The planning committee compromises Thomas David MD, Joseph Friedman, MD, Edward Jackson, MD, Susie Seaman, NP, Daniel Harrison, MD, Nick Lombardi, Michael Kearney, Kristen Petitto, Randy Robbin, Jessica Steuerman, and Lynn Rubin, NACCME.
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Friedman: Grant/research support—Acadia, Addey, Avid, GE, EMD Serono, Schering-Plough, Teva; Consultant—Teva, Addey, Lundbeck; Promotional speakers bureau: Teva, GE, UCB
Dr. Harrison: Grant/research support—Bayer Neuroscience
Ms. Seaman: Scientific advisor—Mölnlycke Health Care; Promotional speakers bureau—Mölnlycke
Dr. Davis has disclosed no relevant financial relationships with any commercial interest.
Mr. Kearney, Ms. Petitto, Mr. Robbin, Ms. Rubin, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.
Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc., ViroPharma, Inc., Vertex Pharmaceuticals
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed in the presentations.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Supported by an educational grant from Teva Pharmaceuticals.